MEET OUR EXPERTS
Peter McCullough, MD, MPH, FACC, FAHA, FASN, FNKF, FNLA, FCRSA
Chief Medical Advisor, Truth for Health Foundation; President, Cardiorenal Society of America; Editor-in-Chief, Reviews in Cardiovascular Medicine; Senior Associate Editor, American Journal of Cardiology
America Out Loud: The McCullough Report
Dr. Peter McCullough is an internist, cardiologist, and epidemiologist. He practices both internal medicine including the management of common infectious diseases as well as the cardiovascular complications of both the viral infection and the injuries developing after the COVID-19 vaccine in Dallas TX, USA. Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multi-drug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 46 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in The Hill, America Out Loud, and on Fox News Channel. On November 19, 2020, Dr. McCullough testified before the U.S. Senate Committee on Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on Health and Human Services, Colorado General Assembly, New Hampshire Senate, and South Carolina Senate concerning many aspects of the pandemic response. Dr. McCullough has dedicated over a year of academic and clinical efforts to combating the SARS-CoV-2 virus and in doing so, has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and is considered among the world’s experts on COVID-19.
Vladimir “Zev” Zelenko, MD, Z”L, ~ In Memoriam ~
Dr. Vladimir (“Zev”) Zelenko served as a family physician in Monroe and Monsey, N.Y., for fifteen years. He was proud to be described by his patients as a family member to thousands of families. He graduated summa cum laude with a B.A. degree with high honors in chemistry from Hofstra University and earned his MD degree from SUNY Buffalo school of medicine. Dr. Zelenko completed his family medicine residency at South Nassau Communities Hospital in Oceanside, N.Y. In March of 2020, the community that Dr. Zelenko serves had one of the first and largest COVID-19 outbreaks in the United States. Dr. Zelenko successfully developed a pre-hospital treatment approach for COVID-19 and is considered a pioneer in the early treatment of the global pandemic. The Zelenko Protocol is based on the early treatment of COVID-19 in high risk patients with a combination of anti-viral and anti-inflammatory medications. Dr. Zelenko was born in Kiev, Ukraine and immigrated to the United States in 1978. He passed away on June 30, 2022 in Dallas, TX. He is survived by his wife and eight children. He founded the ZFreedom Foundation to continue his work fighting for patients’ rights and medical independence.
WATCH Dr. Zelenko’s videos here.
Harvey Risch, MD, PhD, FACE
Dr. Harvey Risch is a practicing epidemiologist with more than 40 years of experience researching the etiology of cancer, including pancreas, ovarian and other cancers. He holds an academic appointment as Professor of Epidemiology at the Yale School of Public Health, Yale School of Medicine, and Yale Cancer Center. Dr. Risch received his Bachelor of Science in mathematics and biology from the California Institute of Technology in 1972 and completed medical training at UC San Diego School of Medicine in 1976. He completed a PhD in biomathematics in 1980 at the University of Chicago, focused on quantitative solutions for the general stochastic epidemic model. Dr. Risch has published more than 350 peer-reviewed original research papers in well-regarded scientific journals and has an h-index of 94, with more than 43,000 publication citations to-date.
Dr. Risch has served as peer reviewer for more than 50 scientific and medical journals. He has been Associate Editor of the Journal of the National Cancer Institute since 2000, Editor pro tem of the American Journal of Epidemiology from 2002-2014 and member of the Board of Editors of this journal from 2014-2020, and Editor of the International Journal of Cancer since 2008. In May 2020, Dr. Risch published the seminal paper on early treatment of high-risk COVID-19 outpatients in the American Journal of Epidemiology, which has been downloaded 88,000 times and viewed by more than 130,000. Dr. Risch was senior author on a groundbreaking outpatient clinical trial study in Brazil, and has co-authored two papers [1, 2] that form the now-standard understanding of early outpatient COVID-19 management. Dr. Risch gave testimony about early COVID-19 treatment before the U.S. Senate in November 2020.
George Fareed, MD
Dr. George Fareed graduated from Harvard Medical School with Honors, 1970 and completed a medical internship at Peter Bent Brigham Hospital 1970-1971. He worked as a research associate at NIAID 1971-1973 and then joined the faculty at Harvard Medical School in 1973 with research and teaching appointment as Associate Professor at UCLA School of Medicine, 1976-1982. He was a founder and director of scientific planning of a biotech company, Ingene (International Genetic Engineering, Inc.), 1982-1990. Since 1991 he has worked clinically in primary medical care in the Imperial Valley of California. He received a Border Hero Award for HIV clinical care in 2008 and the Plessner Award (rural physician of the year) from the California Medical Association. He has been on the frontline for early COVID-19 treatment in the Imperial Valley since March 2020 and has practiced across the whole spectrum of COVID-19 care, treating outpatients as well as inpatients as a hospitalist. He testified on November 19, 2020 in the Senate Hearing on early COVID-19 treatment.
Brian Tyson, MD
Dr. Brian Tyson is a board certified family practitioner who worked as an emergency physician at Arrowhead Regional Medial center for 13 years as well as working as a hospitalist physician for 14 years before opening his own Urgent Care in 2018. Dr. Tyson was the Program Medical Director for Cogent Healthcare and Beaver medical group. His experience with COVID-19 has been exceptional, with over 30,000 patients evaluated, over 5000 positive cases, only one hospitalization and zero deaths with early treatment. His urgent care serves a very high-risk population including two nursing homes, and his success was due to his aggressive early management. Due to his proven methodology, he is considered a frontline COVID-19 treatment expert and has been featured on multiple media sites.
WATCH Dr. Tyson’s videos here.
Stephen Smith, MD
After graduating with a degree in mathematics from Duke University in 1985, Dr. Stephen Smith matriculated at Yale University School of Medicine, then pursued an education in clinical medicine and in molecular virology, focused on infectious diseases. He is an active clinician with over 40 peer-reviewed publications and several patents. In 2009, Dr. Smith and his wife founded the Smith Center for Infectious Diseases and Urban Health, focusing on inner city patients with infectious diseases such as HIV or hepatitis C virus. In March 2020 his entire team dedicated itself to COVID-19 and became the first clinicians to observe the connection between diabetes and severe COVID. Altogether they have treated over 500 COVID-19 inpatients.
Kelly Victory, MD
Dr. Kelly Victory is a residency-trained trauma and emergency specialist with over 30 years of clinical experience. She is an expert in disaster preparedness and response and medical management of mass casualties. Dr. Victory is an alumnus of the National Preparedness Leadership Initiative by the Harvard School of Public Health and the Kennedy School of Government to develop “meta-leaders” for national disaster preparedness and response, and served as a member of the Leadership Council at Harvard School of Public Health for many years. Dr. Victory has worked with a range of public and private organizations including companies, hospitals, schools, churches and municipalities on public health issues including disaster and pandemic preparedness and response.
Dr. Victory teaches “Active Shooter Rapid Response and Extraction” and “Leadership in Times of Crisis” for first responders, community leaders and organizations, aimed at limiting casualties, improving outcomes, enhancing resiliency and coordinating emergency response efforts. Dr. Victory has been a consistent and vocal proponent of aggressive early outpatient treatment for COVID-19, as well as a cautious and informed, risk-based approach to COVID vaccination. She makes frequent radio and television appearances to discuss issues of public health, disasters, and preparedness and response efforts, and has been the daily voice of “The Doctor Hour” on KABC in Los Angeles throughout the pandemic. Dr. Victory holds a BS from Duke University, earned her MD from the University of North Carolina and completed her residency in Emergency Medicine and Trauma at Carolinas Medical Center.
WATCH Dr. Kelly Victory’s videos here.
Joe Brewer, MD
Dr. Joseph Brewer is an infectious disease specialist in Kansas City, Mo. Dr. Brewer is in private practice with Plaza Infectious Disease and also is a consulting physician at St. Luke’s Hospital of Kansas City. He is an assistant clinical professor of medicine at the University of Missouri – Kansas City School of Medicine. Dr. Brewer is involved in clinical teaching at St. Luke’s and UMKC. He has been in practice for over 30 years including clinical practice of infectious disease, teaching responsibilities and clinical research.
Paul Alexander, PhD
Paul Alexander holds a masters of science in clinical epidemiology and community health from the University of Toronto, a masters of science in evidence-based medicine from Oxford University, and a PhD in evidence-based medicine and research methods from McMasters University, Hamilton. He worked as an epidemiologist for the Canadian government for over a decade and was stationed overseas as the Canadian epidemiologist on an international project on TB-HIV co-infection control in South Asia, overseeing the SAARC Project for India, Pakistan, Nepal, Bhutan, Maldives, Sri Lanka, Bangladesh, and Afghanistan. Alexander worked as a regional epidemiologist for the World Health Organization for Europe, overseeing activities in Russia, Poland, Turkey, and Ukraine during the one-year posting. He also served the Infectious Diseases Society of America as a research methodologist helping develop their infectious diseases guidelines from 2017 -2020. He served in the Trump Administration as a senior COVID-19 advisor for the Assistant Secretary of Health and Human Services, and also worked for WHO and the Pan-American Health Organization in Washington, D.C. from February 2020 onwards as a COVID-19 consultant for research methods and related matters.
Ramin Oskoui, MD, FACP
Dr. Ramin Oskoui is a cardiologist certified in cardiovascular disease by the American Board of Internal Medicine. He is CEO of Foxhall Cardiology in Washington, D.C. He has expertise in acute coronary syndromes, cardiac catheterization, cardiomyopathy, cardiovascular disease, congenital heart disease, valvular heart disease, echocardiography and transesophageal echocardiography, high cholesterol, hypertension, pacemakers and preventive cardiology. Dr. Oskoui earned his medical degree from Columbia University College of Physicians and Surgeons. He completed a residency in internal medicine at Georgetown University Hospital and a fellowship in cardiology at Washington Hospital Center. He is a fellow of the American College of Cardiology and the American College of Physicians. He was named 2015 Physician of the Year by Johns Hopkins Medicine Clinical Awards for Physicians and Care Teams, won the annual Patients’ Choice Award many times and was named a Top Doctor in the Washington, D.C.-Baltimore area by Castle Connolly and Washingtonian Magazine. Dr. Oskoui has also received Compassionate Doctor Recognition and was named a 2014 Top 10 Doctor in the District of Columbia for Cardiologists. Dr. Oskoui advised the Trump administration on Covid-19 issues and testified before the U.S. Senate about COVID-19 treatment in November 2020.
Sabine Hazan, MD
A specialist in gastroenterology, internal medicine, and hepatology, Dr. Sabine Hazan is the founder and CEO of Progenabiome, a genetic sequencing research laboratory, and has led over 35 studies investigating the role of the gut flora in various diseases (current list here). Dr. Hazan is also the CEO of Ventura Clinical Trials, where she has over 20 years of experience leading clinical trials for cutting-edge research on various medical issues. Since March 2020, she has been at the forefront of COVID-19 research, leading ongoing FDA-approved clinical trials for treatment and prophylaxis (see details). Through their study exploring the role of the gut flora in COVID-19, Progenabiome became the first lab in the world to detect SARS-CoV-2 from Patient Fecal Samples by Whole Genome Sequencing. With these findings and extensive knowledge on the Microbiome and disease, Dr. Hazan and her partner at Topelia Therapeutics, Dr. Thomas Borody, developed Biome Boosters, a natural vitamin protocol to serve as a first line of defense against COVID-19. Hazan and Borody also co-authored Let’s Talk Shit, a humorous, easy-to-digest explanation of gastrointestinal disorders, treatments, and next generation hope for gut-related diseases.
The first woman ever accepted into the University of Florida as a Clinical Gastroenterology Fellow, Dr. Sabine Hazan is a pioneer in the medical field. She has published articles in numerous prestigious medical journals, and is the Series Editor on the microbiome for Practical Gastroenterology, a peer review journal that reaches 18,000 gastroenterologists. She is also a speaker for the World Congress of Digestive Disease, MAGI, Microbiome Congress, International Drug Discovery Science and Technology Conference and NIST (National Institute of Standards and Technology).